MedPath

Effect of Leucine-rich essential amino acid mixture food (amino care jelly Leucine 40) on exercise therapy in NAFLD (Pilot Trial)

Not Applicable
Recruiting
Conditions
on-alcoholic fatty liver disease
Registration Number
JPRN-UMIN000019598
Lead Sponsor
Faculty of Medicine, Saga University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients with viral hepatitis (2) Liver cirrhosis patients (3) Patients with malignant tumor (not included after radical) (4) Individuals with a history of cardiovascular or cerebrovascular Diseases (5) Severe liver disease (6) Severe renal disease (7) Patients with rush by "amino care jelly Leucine 40"

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ongitudinal change in skeletal muscle tissue fat accumulation by IMAC
Secondary Outcome Measures
NameTimeMethod
Skeletal muscle volume, insulin resistance, liver function, serum lipid, glucose metabolism, inflammatory markers, and each parameter
© Copyright 2025. All Rights Reserved by MedPath